Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients
From early-stage seed investment through to expansion capital, we are able to support life science companies from proof-of-concept through to commercialisation.
Brandon Capital Funds
Brandon has been successful in raising successive funds that collectively cover the spectrum of life science venture investing. We also have a co-investment arrangement with our investors, providing significant capacity to support our advancing portfolio companies.
We currently manage five funds, with more than $700 million of capital under management
MRCF 5 - MRCF5 provides seed stage investment for early-stage life science opportunities associated with MRCF Member organisations. MRCF5 has the capacity to continue to support opportunities into clinical development and commercialisation.
MRCF BTF - The MRCF BTF is focussed on supporting clinical stage, Australian, biomedical opportunities.
MRCF3 - MRCF3 provides seed stage investment for early-stage life science opportunities associated with MRCF Member organisations. MRCF3 has the capacity to continue to support opportunities into clinical development and commercialisation.
MRCF1 and MRCF2 (MRCF IIF, LP and MRCF Trust) - now fully invested
Brandon Biosciences Fund 1 (BBF1 IIF and BBF1 Trust) - now fully invested
AUD$
Investment Portfolio
Recognising the effort required to commercialise a great idea, we partner with entrepreneurs for the long-haul, working collaboratively with them to support the development and commercialisation of their technology, thereby creating value for their teams, our investors and ultimately benefiting patients.
We like to invest early - we have been the founding investor for most of our current portfolio companies
